Production of lentiviral vectors using novel, enzymatically produced, linear DNA
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5462
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Production of lentiviral vectors using novel, enzymatically produced, linear DNA ; day:14 ; month:1 ; year:2019 ; pages:1-7
Gene therapy ; (14.1.2019), 1-7
- Urheber
-
Karda, Rajvinder
Counsell, John R.
Karbowniczek, Kinga
Caproni, Lisa J.
Tite, John P.
Waddington, Simon N.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41434-018-0056-1
- URN
-
urn:nbn:de:101:1-2019022000515843972331
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Karda, Rajvinder
- Counsell, John R.
- Karbowniczek, Kinga
- Caproni, Lisa J.
- Tite, John P.
- Waddington, Simon N.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Lentiviral vectors : with 8 tables
Clinical use of lentiviral vectors
Targeted cell entry of lentiviral vectors
Reconstructing the immune system with lentiviral vectors
Producing lentiviral vectors for ex vivo organ gene therapy
Targeted lentiviral vectors pseudotyped with the Tupaia paramyxovirus glycoproteins
Antibody‐Based CAR T Cells Produced by Lentiviral Transduction
Engineering lentiviral vectors for modulation of dendritic cell apoptotic pathways
Lentiviral vectors as a tool for studying ependyma-specific proteins
High yield sterile filtration process for highly concentrated lentiviral vectors
Optimized lentiviral gene therapeutic vectors for prolonged and stable transgene expression
Downstream processing of lentiviral vectors with focus on steric exclusion chromatography
Lentiviral vectors : with 8 tables
Clinical use of lentiviral vectors
Targeted cell entry of lentiviral vectors
Reconstructing the immune system with lentiviral vectors
Producing lentiviral vectors for ex vivo organ gene therapy
Targeted lentiviral vectors pseudotyped with the Tupaia paramyxovirus glycoproteins
Antibody‐Based CAR T Cells Produced by Lentiviral Transduction
Engineering lentiviral vectors for modulation of dendritic cell apoptotic pathways
Lentiviral vectors as a tool for studying ependyma-specific proteins
High yield sterile filtration process for highly concentrated lentiviral vectors
Optimized lentiviral gene therapeutic vectors for prolonged and stable transgene expression
Downstream processing of lentiviral vectors with focus on steric exclusion chromatography
Lentiviral vectors : with 8 tables
Clinical use of lentiviral vectors
Targeted cell entry of lentiviral vectors
Reconstructing the immune system with lentiviral vectors
Producing lentiviral vectors for ex vivo organ gene therapy
Targeted lentiviral vectors pseudotyped with the Tupaia paramyxovirus glycoproteins
Antibody‐Based CAR T Cells Produced by Lentiviral Transduction
Engineering lentiviral vectors for modulation of dendritic cell apoptotic pathways
Lentiviral vectors as a tool for studying ependyma-specific proteins
High yield sterile filtration process for highly concentrated lentiviral vectors
Optimized lentiviral gene therapeutic vectors for prolonged and stable transgene expression